GSK PLC Director/PDMR Shareholding (0214N)
18 January 2023 - 2:30AM
UK Regulatory
TIDMGSK
RNS Number : 0214N
GSK PLC
17 January 2023
GSK plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Ms E Walmsley
==== ====================================== ======================================================
b) Position/status Chief Executive Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 577
======================================================================= ======================
GBP14.3100 480
======================================================================= ======================
GBP14.3100 719
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 1,776
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr I Mackay
==== ====================================== ======================================================
b) Position/status Chief Financial Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 390
======================================================================= ======================
GBP14.3100 333
======================================================================= ======================
GBP14.3100 497
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 1,220
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Dr H Barron
==== ======================================== ====================================================
b) Position/status Non-Executive Director
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W2044
==== ======================================== ====================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 12 January 2023 on ADSs
held in the Company's Deferred Annual Bonus
Plan
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =========================
$35.1500 326
====================== =========================
$35.1500 247
====================== =========================
$35.1500 390
====================== =========================
d) Aggregated information
====
Aggregated volume 963
Price
$35.1500
==================================================================================================
e) Date of the transaction 2023-01-16
==== ======================================== ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Ms D Conrad
==== ====================================== ======================================================
b) Position/status Chief People Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 75
======================================================================= ======================
GBP14.3100 69
======================================================================= ======================
GBP14.3100 112
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 256
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr J Ford
==== ====================================== ======================================================
b) Position/status SVP and Group General Counsel, Legal and
Compliance
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 107
======================================================================= ======================
GBP14.3100 83
======================================================================= ======================
GBP14.3100 139
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 329
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Ms S Jackson
==== ====================================== ======================================================
b) Position/status SVP, Global Communications and CEO Office
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 45
======================================================================= ======================
GBP14.3100 42
======================================================================= ======================
GBP14.3100 64
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 151
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr L Miels
==== ====================================== ======================================================
b) Position/status Chief Commercial Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 174
======================================================================= ======================
GBP14.3100 130
======================================================================= ======================
GBP14.3100 236
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 540
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Ms S Ramakrishnan
==== ======================================== ====================================================
b) Position/status Chief Digital and Technology Officer
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W2044
==== ======================================== ====================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 12 January 2023 on ADSs
held in the Company's Deferred Annual Bonus
Plan
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =========================
$35.1500 23
====================== =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ========================================================
e) Date of the transaction 2023-01-16
==== ======================================== ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr D Redfern
==== ====================================== ======================================================
b) Position/status President Corporate Development
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 128
======================================================================= ======================
GBP14.3100 102
======================================================================= ======================
GBP14.3100 156
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 386
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr R Simard
==== ====================================== ======================================================
b) Position/status President, Global Supply Chain
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 90
======================================================================= ======================
GBP14.3100 77
======================================================================= ======================
GBP14.3100 142
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 309
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr P Thomson
==== ====================================== ======================================================
b) Position/status President, Global Affairs
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 74
======================================================================= ======================
GBP14.3100 59
======================================================================= ======================
GBP14.3100 98
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 231
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Ms D Waterhouse
==== ====================================== ======================================================
b) Position/status CEO, ViiV Healthcare
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 12 January 2023
on Ordinary Shares held in the Company's
Deferred Annual Bonus Plan
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 123
======================================================================= ======================
GBP14.3100 104
======================================================================= ======================
d) Aggregated information
====
Aggregated volume 227
Price GBP14.3100
====================================== ===========================================================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================
a) Name Ms E Walmsley
=== ======================== ================================================
b) Position/status Chief Executive Officer
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GSK plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ======================== ================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 12 January 2023 on Ordinary
Shares held in the Company's Performance
Share Plan subject to a 2-year holding
period
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP14.3100 6,304.099
----------
=== ======================== ================================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ================================================
e) Date of the transaction 2023-01-16
=== ======================== ================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr I Mackay
==== ====================================== ======================================================
b) Position/status Chief Financial Officer
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GSK plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
==== ====================================== ======================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 12 January 2023 on Ordinary
Shares held in the Company's Performance
Share Plan subject to a 2-year holding
period
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP14.3100 1,517.833
======================================================================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2023-01-16
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHSFIFLWEDSEDF
(END) Dow Jones Newswires
January 17, 2023 10:30 ET (15:30 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
